The report covers forecast and analysis for the pharmaceutical intermediates market on a global and regional level. The study provides historical data from 2015 to 2017 along with a forecast from 2018 to 2024 based on revenue (USD Million). The study includes drivers and restraints for the pharmaceutical intermediates market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the pharmaceutical intermediates market on a global level.
In order to give the users of this report a comprehensive view of the pharmaceutical intermediates market, we have included competitive landscape and analysis of Porter’s Five Forces model in the market. The study encompasses a market attractiveness analysis, where product type, application, distribution channel, and regional segmentation are benchmarked based on their market size, growth rate, and general attractiveness.
The report provides company market share analysis in order to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments in the market, including acquisitions & mergers, new product launches, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants in the market on the global and regional basis.
The study provides a decisive view of the pharmaceutical intermediates market by segmenting the market based on product type, application, distribution channel, and regions. All the segments have been analyzed based on present and future trends and the market are estimated from 2018 to 2024.
Based on product type, the pharmaceutical intermediates market is segmented as GMP and Non GMP. Based on the application, the pharmaceutical intermediates market is segmented into antibiotics, antipyretic analgesics, vitamins, and others. Based on the distribution channel, the pharmaceutical intermediates market is segmented as direct sales and distributor.
Increased prevalence of various diseases is one of the major driving factors of pharmaceutical intermediates market. Increased demand for pharmaceuticals coupled with a rise in research and development activities are likely to lead to the innovation of new and advanced products that are expected to promote the growth of pharmaceutical intermediates market. However, stringent regulations are predicted to influence market growth during the forecast period.
The regional segmentation includes the current and forecast demand for the product in North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa that are further divided into major countries, including the U.S., Germany, France, the UK, China, Japan, India, and Brazil. This segment includes demand for pharmaceutical intermediates market based on individual segment and treatment in all the regions and countries.
The report also includes detailed profiles of end players such as Aceto Corporation, Easter Chemical Corporation, BASF SE, A.R. Life Sciences Private Limited, Vertellus Holdings LLC, Lianhetech, Dishman Group, Midas Pharma GmbH, Codexis, Inc., Chemcon Specialty Chemical Pvt. Ltd., Cycle Pharma, Dextra Laboratories Ltd., Sanofi Winthrop Industries S.A., and ZCL Chemicals Ltd.
This report segments the global pharmaceutical intermediates market as follows:
Global Pharmaceutical Intermediates Market: Product Type Segment Analysis
- GMP
- Non GMP
Global Pharmaceutical Intermediates Market: Application Segment Analysis
- Antibiotics.
- Antipyretic analgesics
- Vitamins
- Other
Global Pharmaceutical Intermediates Market: Distribution Channel Segment Analysis
- Direct Sales
- Distributor
Global Pharmaceutical Intermediates Market: Regional Analysis
- North America
- The U.S.
- Europe
- UK
- France
- Germany
- Asia Pacific
- China
- Japan
- India
- Latin America
- Brazil
- Middle East and Africa
Table of Contents
- Chapter 1. Introduction
- 1.1. Report description and scope
- 1.2. Research scope
- 1.3. Research methodology
- 1.3.1. Market research process
- 1.3.2. Market research methodology
- Chapter 2. Executive Summary
- 2.1. Global Pharmaceutical Intermediates Market, 2015 - 2024 (USD Million)
- 2.2. Global Pharmaceutical Intermediates Market: Snapshot
- Chapter 3. Pharmaceutical Intermediates Market Dynamics
- 3.1. Introduction
- 3.2. Market drivers
- 3.2.1. Global Pharmaceutical Intermediates Market drivers: Impact analysis
- 3.2.2. Increased burden of various diseases
- 3.2.3. Increase in research and development activities led to the innovation of new products
- 3.3. Market Restraints
- 3.3.1. Stringent regulatory policies
- 3.4. Opportunities
- 3.4.1. High spending on R&D
- 3.5. Porter's five forces analysis
- 3.5.1. Bargaining power of suppliers
- 3.5.2. Bargaining power of buyers
- 3.5.3. Threat from new entrants
- 3.5.4. Threat from new substitutes
- 3.5.5. Degree of competition
- 3.6. Market attractiveness analysis
- 3.6.1. Market attractiveness analysis, by Product Type
- 3.6.2. Market attractiveness analysis, by Application
- 3.6.3. Market attractiveness analysis, by Distribution Channel
- 3.6.4. Market attractiveness analysis, by Regional Segment
- Chapter 4. Global Pharmaceutical Intermediates Market - Competitive Landscape
- 4.1. Company Market Share Analysis
- 4.1.1. Global Pharmaceutical Intermediates Market: company market share, 2015
- 4.2. Strategic Development
- 4.2.1. Acquisitions & Mergers
- 4.2.2. New Product Type Launch
- 4.2.3. Agreements, Partnerships, Collaborations and Joint Ventures
- 4.2.4. Research and Development, Regional Expansion
- 4.1. Company Market Share Analysis
- Chapter 5. Global Pharmaceutical Intermediates Market - Product Type Segment Analysis
- 5.1. Global Pharmaceutical Intermediates Market: Product Type overview
- 5.1.1. Global Pharmaceutical Intermediates Market revenue share, by Product Type, 2015 and 2024(USD Million)
- 5.2. GMP
- 5.2.1. Global GMP market, 2015 - 2024(USD Million)
- 5.3. Non GMP
- 5.3.1. Global Non GMP market, 2015 - 2024(USD Million)
- 5.1. Global Pharmaceutical Intermediates Market: Product Type overview
- Chapter 6. Global Pharmaceutical Intermediates Market - Application Segment Analysis
- 6.1. Global Pharmaceutical Intermediates Market: Application overview
- 6.1.1. Global Pharmaceutical Intermediates Market revenue share, by indication, 2015 and 2024(USD Million)
- 6.2. Antibiotics
- 6.2.1. Global Antibiotics market, 2015 - 2024(USD Million)
- 6.3. Antipyretic analgesics
- 6.3.1. Global Antipyretic analgesics market, 2015 - 2024(USD Million)
- 6.4. Vitamins
- 6.4.1. Global Vitamins market, 2015 - 2024(USD Million)
- 6.5. Other
- 6.5.1. Global Other market, 2015 - 2024(USD Million)
- 6.1. Global Pharmaceutical Intermediates Market: Application overview
- Chapter 7. Global Pharmaceutical Intermediates Market - Distribution Channel Segment Analysis
- 7.1. Global Pharmaceutical Intermediates Market: Distribution Channel overview
- 7.1.1. Global Pharmaceutical Intermediates Market revenue share, by Distribution Channel , 2014 and 2024(USD Million)
- 7.2. Direct Sales
- 7.2.1. Global Pharmaceutical Intermediates Market for Direct Sales, 2015 - 2024(USD Million)
- 7.3. Distributor
- 7.3.1. Global Pharmaceutical Intermediates Market for Distributor, 2015 - 2024(USD Million)
- 7.1. Global Pharmaceutical Intermediates Market: Distribution Channel overview
- Chapter 8. Global Pharmaceutical Intermediates Market - Regional Segment Analysis
- 8.1. Global Pharmaceutical Intermediates Market: Regional overview
- 8.1.1. Global Pharmaceutical Intermediates Market revenue share, by Region, 2015 and 2024
- 8.2. North America
- 8.2.1. North America Pharmaceutical Intermediates Market revenue, by Product Type, 2015 - 2024(USD Million)
- 8.2.2. North America Pharmaceutical Intermediates Market revenue, by Application, 2015 - 2024(USD Million)
- 8.2.3. North America Pharmaceutical Intermediates Market revenue, by Distribution Channel , 2015 - 2024(USD Million)
- 8.2.4. North America Pharmaceutical Intermediates Market revenue, by Region, 2015 - 2024(USD Million)
- 8.2.5. U.S.
- 8.2.5.1. U.S. Pharmaceutical Intermediates Market revenue, by Product Type, 2015 - 2024(USD Million)
- 8.2.5.2. U.S. Pharmaceutical Intermediates Market revenue, by Application, 2015 - 2024(USD Million)
- 8.2.5.3. U.S. Pharmaceutical Intermediates Market revenue, by Distribution Channel , 2015 - 2024(USD Million)
- 8.2.5.4. U.S. Pharmaceutical Intermediates Market revenue, by Region, 2015 - 2024(USD Million)
- 8.2.6. Rest of North America
- 8.2.6.1. Rest of North America Pharmaceutical Intermediates Market revenue, by Product Type, 2015 - 2024(USD Million)
- 8.2.6.2. Rest of North America Pharmaceutical Intermediates Market revenue, by Application, 2015 - 2024(USD Million)
- 8.2.6.3. Rest of North America Pharmaceutical Intermediates Market revenue, by Distribution Channel, 2015 - 2024(USD Million)
- 8.2.6.4. Rest of North America Pharmaceutical Intermediates Market revenue, by Region, 2015 - 2024(USD Million)
- 8.3. Europe
- 8.3.1. Europe Pharmaceutical Intermediates Market revenue, by Product Type, 2015 - 2024(USD Million)
- 8.3.2. Europe Pharmaceutical Intermediates Market revenue, by Application, 2015 - 2024(USD Million)
- 8.3.3. Europe Pharmaceutical Intermediates Market revenue, by Distribution Channel , 2015 - 2024(USD Million)
- 8.3.4. Europe Pharmaceutical Intermediates Market revenue, by Region, 2015 - 2024(USD Million)
- 8.3.5. Germany
- 8.3.5.1. Germany Pharmaceutical Intermediates Market revenue, by Product Type, 2015 - 2024(USD Million)
- 8.3.5.2. Germany Pharmaceutical Intermediates Market revenue, by Application, 2015 - 2024(USD Million)
- 8.3.5.3. Germany Pharmaceutical Intermediates Market revenue, by Distribution Channel , 2015 - 2024(USD Million)
- 8.3.5.4. Germany Pharmaceutical Intermediates Market revenue, by Region, 2015 - 2024(USD Million)
- 8.3.6. U.K.
- 8.3.6.1. U.K. Pharmaceutical Intermediates Market revenue, by Product Type, 2015 - 2024(USD Million)
- 8.3.6.2. U.K. Pharmaceutical Intermediates Market revenue, by Application, 2015 - 2024(USD Million)
- 8.3.6.3. U.K. Pharmaceutical Intermediates Market revenue, by Distribution Channel , 2015 - 2024(USD Million)
- 8.3.6.4. U.K. Pharmaceutical Intermediates Market revenue, by Region, 2015 - 2024(USD Million)
- 8.3.7. France
- 8.3.7.1. France Pharmaceutical Intermediates Market revenue, by Product Type, 2015 - 2024(USD Million)
- 8.3.7.2. France Pharmaceutical Intermediates Market revenue, by Application, 2015 - 2024(USD Million)
- 8.3.7.3. France Pharmaceutical Intermediates Market revenue, by Distribution Channel , 2015 - 2024(USD Million)
- 8.3.7.4. France Pharmaceutical Intermediates Market revenue, by Region, 2015 - 2024(USD Million)
- 8.3.8. Rest of Europe
- 8.3.8.1. Rest of Europe Pharmaceutical Intermediates Market revenue, by Product Type, 2015 - 2024(USD Million)
- 8.3.8.2. Rest of Europe Pharmaceutical Intermediates Market revenue, by Application, 2015 - 2024(USD Million)
- 8.3.8.3. Rest of Europe Pharmaceutical Intermediates Market revenue, by Distribution Channel , 2015 - 2024(USD Million)
- 8.3.8.4. Rest of Europe Pharmaceutical Intermediates Market revenue, by Region, 2015 - 2024(USD Million)
- 8.4. Asia Pacific
- 8.4.1. Asia Pacific Pharmaceutical Intermediates Market revenue, by Product Type, 2015 - 2024(USD Million)
- 8.4.2. Asia Pacific Pharmaceutical Intermediates Market revenue, by Application, 2015 - 2024(USD Million)
- 8.4.3. Asia Pacific Pharmaceutical Intermediates Market revenue, by Distribution Channel , 2015 - 2024(USD Million)
- 8.4.4. Asia Pacific Pharmaceutical Intermediates Market revenue, by Region, 2015 - 2024(USD Million)
- 8.4.5. China
- 8.4.5.1. China Pharmaceutical Intermediates Market revenue, by Product Type, 2015 - 2024(USD Million)
- 8.4.5.2. China Pharmaceutical Intermediates Market revenue, by Application, 2015 - 2024(USD Million)
- 8.4.5.3. China Pharmaceutical Intermediates Market revenue, by Distribution Channel , 2015 - 2024(USD Million)
- 8.4.5.4. China Pharmaceutical Intermediates Market revenue, by Region, 2015 - 2024(USD Million)
- 8.4.6. Japan
- 8.4.6.1. Japan Pharmaceutical Intermediates Market revenue, by Product Type, 2015 - 2024(USD Million)
- 8.4.6.2. Japan Pharmaceutical Intermediates Market revenue, by Application, 2015 - 2024(USD Million)
- 8.4.6.3. Japan Pharmaceutical Intermediates Market revenue, by Distribution Channel , 2015 - 2024(USD Million)
- 8.4.6.4. Japan Pharmaceutical Intermediates Market revenue, by region, 2015 - 2024(USD Million)
- 8.4.7. India
- 8.4.7.1. India Pharmaceutical Intermediates Market revenue, by Product Type, 2015 - 2024(USD Million)
- 8.4.7.2. India Pharmaceutical Intermediates Market revenue, by Application, 2015 - 2024(USD Million)
- 8.4.7.3. India Pharmaceutical Intermediates Market revenue, by Distribution Channel , 2015 - 2024(USD Million)
- 8.4.7.4. India Pharmaceutical Intermediates Market revenue, by region, 2015 - 2024(USD Million)
- 8.4.8. Rest of Asia Pacific
- 8.4.8.1. Rest of Asia Pacific Pharmaceutical Intermediates Market revenue, by Product Type, 2015 - 2024(USD Million)
- 8.4.8.2. Rest of Asia Pacific Pharmaceutical Intermediates Market revenue, by Application, 2015 - 2024(USD Million)
- 8.4.8.3. Rest of Asia Pacific Pharmaceutical Intermediates Market revenue, by Distribution Channel , 2015 - 2024(USD Million)
- 8.4.8.4. Rest of Asia Pacific Pharmaceutical Intermediates Market revenue, by region, 2015 - 2024(USD Million)
- 8.5. Latin America
- 8.5.1. Latin America Pharmaceutical Intermediates Market revenue, by Product Type, 2015 - 2024(USD Million)
- 8.5.2. Latin America Pharmaceutical Intermediates Market revenue, by Application, 2015 - 2024(USD Million)
- 8.5.3. Latin America Pharmaceutical Intermediates Market revenue, by Distribution Channel , 2015 - 2024(USD Million)
- 8.5.4. Latin America Pharmaceutical Intermediates Market revenue, by Region, 2015 - 2024(USD Million)
- 8.5.5. Brazil
- 8.5.5.1. Brazil Pharmaceutical Intermediates Market revenue, by Product Type, 2015 - 2024(USD Million)
- 8.5.5.2. Brazil Pharmaceutical Intermediates Market revenue, by Application, 2015 - 2024(USD Million)
- 8.5.5.3. Brazil Pharmaceutical Intermediates Market revenue, by Distribution Channel , 2015 - 2024(USD Million)
- 8.5.5.4. Brazil Pharmaceutical Intermediates Market revenue, by Region, 2015 - 2024(USD Million)
- 8.5.6. Rest of Latin America
- 8.5.6.1. Rest of Latin America Pharmaceutical Intermediates Market revenue, by Product Type, 2015 - 2024(USD Million)
- 8.5.6.2. Rest of Latin America Pharmaceutical Intermediates Market revenue, by Application, 2015 - 2024(USD Million)
- 8.5.6.3. Rest of Latin America Pharmaceutical Intermediates Market revenue, by Distribution Channel , 2015 - 2024(USD Million)
- 8.5.6.4. Rest of Latin America Pharmaceutical Intermediates Market revenue, by Region, 2015 - 2024(USD Million)
- 8.6. Middle East and Africa
- 8.6.1. Middle East and Africa Pharmaceutical Intermediates Market revenue, by Product Type, 2015 - 2024(USD Million)
- 8.6.2. Middle East and Africa Pharmaceutical Intermediates Market revenue, by Application, 2015 - 2024(USD Million)
- 8.6.3. Middle East and Africa Pharmaceutical Intermediates Market revenue, by Distribution Channel , 2015 - 2024(USD Million)
- 8.6.4. Middle East and Africa Pharmaceutical Intermediates Market revenue, by Region, 2015 - 2024(USD Million)
- 8.1. Global Pharmaceutical Intermediates Market: Regional overview
- Chapter 9. Company Profile
- 9.1. Aceto Corporation
- 9.1.1. Overview
- 9.1.2. Financials
- 9.1.3. Application portfolio
- 9.1.4. Business strategy
- 9.1.5. Recent developments
- 9.2. Easter Chemical Corporation
- 9.2.1. Overview
- 9.2.2. Financials
- 9.2.3. Application portfolio
- 9.2.4. Business strategy
- 9.2.5. Recent developments
- 9.3. BASF SE
- 9.3.1. Overview
- 9.3.2. Financials
- 9.3.3. Application portfolio
- 9.3.4. Business strategy
- 9.3.5. Recent developments
- 9.4. A.R. Life Sciences Private Limited
- 9.4.1. Overview
- 9.4.2. Financials
- 9.4.3. Application portfolio
- 9.4.4. Business strategy
- 9.4.5. Recent developments
- 9.5. Vertellus Holdings LLC
- 9.5.1. Overview
- 9.5.2. Financials
- 9.5.3. Application portfolio
- 9.5.4. Business strategy
- 9.5.5. Recent developments
- 9.6. Lianhetech
- 9.6.1. Overview
- 9.6.2. Financials
- 9.6.3. Application portfolio
- 9.6.4. Business strategy
- 9.6.5. Recent developments
- 9.7. Dishman Group
- 9.7.1. Overview
- 9.7.2. Financials
- 9.7.3. Application portfolio
- 9.7.4. Business strategy
- 9.7.5. Recent developments
- 9.8. Midas Pharma GmbH
- 9.8.1. Overview
- 9.8.2. Financials
- 9.8.3. Application portfolio
- 9.8.4. Business strategy
- 9.8.5. Recent developments
- 9.9. Codexis, Inc.,
- 9.9.1. Overview
- 9.9.2. Financials
- 9.9.3. Application portfolio
- 9.9.4. Business strategy
- 9.9.5. Recent developments
- 9.10. Chemcon Specialty Chemical Pvt. Ltd.
- 9.10.1. Overview
- 9.10.2. Financials
- 9.10.3. Application portfolio
- 9.10.4. Business strategy
- 9.10.5. Recent developments
- 9.11. Cycle Pharma
- 9.11.1. Overview
- 9.11.2. Financials
- 9.11.3. Application portfolio
- 9.11.4. Business strategy
- 9.11.5. Recent developments
- 9.12. Dextra Laboratories Limited
- 9.12.1. Overview
- 9.12.2. Financials
- 9.12.3. Application portfolio
- 9.12.4. Business strategy
- 9.12.5. Recent developments
- 9.13. Sanofi Winthrop Industrie S.A.
- 9.13.1. Overview
- 9.13.2. Financials
- 9.13.3. Application portfolio
- 9.13.4. Business strategy
- 9.13.5. Recent developments
- 9.14. ZCL Chemicals Ltd.
- 9.14.1. Overview
- 9.14.2. Financials
- 9.14.3. Application portfolio
- 9.14.4. Business strategy
- 9.14.5. Recent developments
- 9.1. Aceto Corporation
